
Atherothrombosis
Discover more on science updates, events, KOLs interviews and more on Atherothrombosis
Science in Atherothrombosis
Get a 360º view and stay up-to-date on Atherothrombosis with content selected for you

- Cardiovascular
- Atherothrombosis
- Atherothrombosis
No Rebound Effect Post Clopidogrel Withdrawal

- Atherothrombosis
Ticagrelor vs Clopidogrel in ACS patients undergoing PCI in routine clinical practice

- Atherothrombosis
In hospital outcomes in young patients with AMI: Results from Gulf Coast

- Atherothrombosis
Effect of de-escalated P2Y12 inhibitor switching in dual antiplatelet therapy (DAPT)

- Atherothrombosis
Is Clopidogrel a viable first choice P2Y12 inhibitor for DAPT after PCI?
Inspiration and innovation
Get inspired and stay at the forefront of innovation with the following resources

- Cardiovascular
- Atherothrombosis
- Atherothrombosis
No Rebound Effect Post Clopidogrel Withdrawal
.webp/jcr:content/dapt-thumb%20(1).webp)
- Cardiovascular
- Atherothrombosis
- Atherothrombosis
Effectiveness and safety of Clopidogrel vs Aspirin
.webp/jcr:content/Clopidogrel%20as%20the%20standard%20of%20care%20for%20elective%20PCI%20Findings%20from%20the%20ALPHEUS%20(1).webp)
- Atherothrombosis
- Atherothrombosis
Clopidogrel as the standard of care for elective PCI: Findings from the Alpheus

- Atherothrombosis
- Cardiovascular
- Atherothrombosis
Understanding de-escalation in Antiplatelet therapy

- Atherothrombosis
- Atherothrombosis